この地域の糖尿病市場は2020年から2024年にかけて力強い成長を遂げ、年平均成長率（CAGR）8.6%を達成しました。この上昇傾向は今後も続くと予想され、2025年から2029年にかけては6.7%の年平均成長率（CAGR）で成長すると予測されています。2029年末までに、糖尿病市場は2024年の58億7,070万米ドルから約88億4,410万米ドルに拡大すると予測されています。
ラテンアメリカでは、糖尿病装置および治療薬市場を形成する主要なトレンドとして、糖尿病罹患率の上昇、デジタルヘルスソリューションの導入拡大、そして規制および保険償還制度の進化などが挙げられます。今後2〜4年でこれらのトレンドはさらに強まり、糖尿病管理へのアクセス拡大と、より適応性の高い市場環境の形成を促すと予想されます。
ラテンアメリカにおける競争環境は、長年の実績を持つ多国籍企業と新興の現地メーカーの相互作用によって特徴づけられており、戦略的な提携や統合が進む傾向にあります。今後2〜4年間で、プレーヤーが進化する規制枠組みに適応し、デジタルヘルス技術に投資するにつれて、競争環境は激化し、再編されると予想されます。
市場には、既存の多国籍企業と、地域の臨床およびコスト上の課題に対応する新興の現地メーカーが混在しています。最近の業界レポートによると、経済格差と多様な規制環境が市場セグメンテーションと製品提供に影響を与えています。
本レポートは、ラテンアメリカにおける糖尿病業界について、データに基づいた詳細な分析を提供しています。診断・モニタリング機器、治療薬、領域など、幅広い分野にわたる市場機会と分析を網羅しています。国レベルで50以上のKPIを網羅し、糖尿病市場のダイナミクス、市場規模と予測、そして市場シェア統計に関する包括的な理解を提供します。
BioIntel360の調査手法は、業界のベストプラクティスに基づいています。独自の分析プラットフォームを活用した公平な分析により、新興ビジネスおよび投資市場における機会の詳細な洞察を提供します。
1. ラテンアメリカにおける糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
2. ブラジルにおける糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
3. メキシコにおける糖尿病装置および治療薬市場の機会と将来の成長ダイナミクス（データブック）
本レポートは、ラテンアメリカにおける糖尿病装置および治療薬市場（2020〜2029年）について、データに基づいた詳細な分析を提供しています。主要な市場セグメントの概要は以下のとおりです。
目次
Table of Contents
This title from BioIntel360 is a bundled offering, combining the following 3 regional and country reports, covering 120 tables and 162 figures:
Regional Report - Latin America Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 1 - Brazil Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
Country Report 2 - Mexico Diabetes Devices and Therapeutics Market Opportunity and Future Growth Dynamics (Databook)
All global, regional, and country reports mentioned above will have the following tables of contents:
1 About this Report
1.1 Research Methodology
1.2 Disclaimer
2 Diabetes Devices and Therapeutics Market Size and Forecast, 2020-2029
3 Diabetes Devices and Therapeutics Market Share by Category, 2020-2029
3.1 Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, 2020-2029
3.2 Diabetes Devices and Therapeutics Market Size by Therapeutics, 2020-2029
4 Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2020-2029
4.1 Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, 2020-2029
4.2 Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, 2020-2029
4.3 Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, 2020-2029
4.4 Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, 2020-2029
5 Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2020-2029
5.1 Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, 2020-2029
5.2 Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, 2020-2029
5.3 Diabetes Devices and Therapeutics Market Size by Test Strips, 2020-2029
5.4 Diabetes Devices and Therapeutics Market Size by Lancets, 2020-2029
6 Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2020-2029
6.1 Diabetes Devices and Therapeutics Market Size by Insulin Pumps, 2020-2029
6.2 Diabetes Devices and Therapeutics Market Size by Insulin Pens, 2020-2029
6.3 Diabetes Devices and Therapeutics Market Size by Insulin Syringes, 2020-2029
7 Diabetes Devices and Therapeutics Market Share by Therapeutics, 2020-2029
7.1 Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, 2020-2029
7.2 Diabetes Devices and Therapeutics Market Size by Insulin, 2020-2029
7.3 Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, 2020-2029
7.4 Diabetes Devices and Therapeutics Market Size by Combination Drugs, 2020-2029
8 Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2020-2029
8.1 Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors, 2020-2029
8.2 Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors, 2020-2029
8.3 Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors, 2020-2029
9 Diabetes Devices and Therapeutics Market Share by Insulin, 2020-2029
9.1 Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, 2020-2029
9.2 Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, 2020-2029
9.3 Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, 2020-2029
9.4 Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, 2020-2029
10 Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2020-2029
10.1 Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, 2020-2029
10.2 Diabetes Devices and Therapeutics Market Size by Amylin Analogue, 2020-2029
11 Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2020-2029
11.1 Diabetes Devices and Therapeutics Market Size by Combination Insulin, 2020-2029
11.2 Diabetes Devices and Therapeutics Market Size by Oral Combination, 2020-2029
12 Diabetes Devices and Therapeutics Market Share by Route of Administration, 2020-2029
12.1 Diabetes Devices and Therapeutics Market Size by Subcutaneous, 2020-2029
12.2 Diabetes Devices and Therapeutics Market Size by Intravenous, 2020-2029
12.3 Diabetes Devices and Therapeutics Market Size by Others, 2020-2029
13 Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2020-2029
13.1 Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, 2020-2029
13.2 Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, 2020-2029
14 Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2020-2029
14.1 Diabetes Devices and Therapeutics Market Size by Online Pharmacies, 2020-2029
14.2 Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, 2020-2029
14.3 Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, 2020-2029
15 Diabetes Devices and Therapeutics Market Share by End User, 2020-2029
15.1 Diabetes Devices and Therapeutics Market Size by Hospitals, 2020-2029
15.2 Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, 2020-2029
15.3 Diabetes Devices and Therapeutics Market Size by Homecare, 2020-2029
16 Further Reading
16.1 About BioIntel360
16.2 Related Research
16.3 Consulting
List of Tables
This bundled offering has 40 tables across 3 regional and country reports. All regional and country reports will have the following tables:
Table 1: Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Table 2: Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Table 3: Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Table 4: Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 5: Diabetes Devices and Therapeutics Market Size by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Table 6: Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Table 7: Diabetes Devices and Therapeutics Market Size by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Table 8: Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Table 9: Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Table 10: Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Table 11: Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Table 12: Diabetes Devices and Therapeutics Market Size by Insulin Pumps, by Value (US$ Million) 2020-2029
Table 13: Diabetes Devices and Therapeutics Market Size by Insulin Pens, by Value (US$ Million) 2020-2029
Table 14: Diabetes Devices and Therapeutics Market Size by Insulin Syringes, by Value (US$ Million) 2020-2029
Table 15: Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Table 16: Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Table 17: Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Table 18: Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Table 19: Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Table 20: Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Table 21: Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Table 22: Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Table 23: Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Table 24: Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Table 25: Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Table 26: Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Table 27: Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Table 28: Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Table 29: Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Table 30: Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Table 31: Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Table 32: Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Table 33: Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Table 34: Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Table 35: Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Table 36: Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Table 37: Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Table 38: Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Table 39: Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Table 40: Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
List of Figures
This bundled offering has 53 figures across 3 regional and country reports. All regional and country reports will have the following figures:
Figure 1: Diabetes Devices and Therapeutics Market Size by Value (US$ Million) 2020-2029
Figure 2: Diabetes Devices and Therapeutics Market Share by Category (%), 2020-2029
Figure 3: Diabetes Devices and Therapeutics Market Size by Diagnosis and Monitoring Devices, by Value (US$ Million), 2020-2029
Figure 4: Diabetes Devices and Therapeutics Market Size by Therapeutics, by Value (US$ Million) 2020-2029
Figure 5: Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices (%), 2020-2029
Figure 6: Diabetes Devices and Therapeutics Market Size by Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 7: Diabetes Devices and Therapeutics Market Size, by Insulin Delivery Devices, by Value (US$ Million) 2020-2029
Figure 8: Diabetes Devices and Therapeutics Market Size by Diabetes Management and Mobile Applications, by Value (US$ Million) 2020-2029
Figure 9: Diabetes Devices and Therapeutics Market Size, by Artificial Pancreas Devices, by Value (US$ Million) 2020-2029
Figure 10: Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices (%), 2020-2029
Figure 11: Diabetes Devices and Therapeutics Market Size by Self-Monitoring Blood Glucose Devices, by Value (US$ Million) 2020-2029
Figure 12: Diabetes Devices and Therapeutics Market Size by Continuous Blood Glucose Monitoring Devices, by Value (US$ Million) 2020-2029
Figure 13: Diabetes Devices and Therapeutics Market Size by Test Strips, by Value (US$ Million) 2020-2029
Figure 14: Diabetes Devices and Therapeutics Market Size by Lancets, by Value (US$ Million) 2020-2029
Figure 15: Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices (%), 2020-2029
Figure 16: Diabetes Devices and Therapeutics Market Share by Insulin Pumps, by Value (US$ Million) 2020-2029
Figure 17: Diabetes Devices and Therapeutics Market Share by Insulin Pens, by Value (US$ Million) 2020-2029
Figure 18: Diabetes Devices and Therapeutics Market Share by Insulin Syringes, by Value (US$ Million) 2020-2029
Figure 19: Diabetes Devices and Therapeutics Market Share by Therapeutics (%), 2020-2029
Figure 20: Diabetes Devices and Therapeutics Market Size by Oral Anti-Diabetic Drugs, by Value (US$ Million), 2020-2029
Figure 21: Diabetes Devices and Therapeutics Market Size by Insulin, by Value (US$ Million), 2020-2029
Figure 22: Diabetes Devices and Therapeutics Market Size by Non-Insulin Injectable Drugs, by Value (US$ Million), 2020-2029
Figure 23: Diabetes Devices and Therapeutics Market Size by Combination Drugs, by Value (US$ Million), 2020-2029
Figure 24: Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs (%), 2020-2029
Figure 25: Diabetes Devices and Therapeutics Market Size by Alpha-Glucosidase Inhibitors (US$ Million), 2020-2029
Figure 26: Diabetes Devices and Therapeutics Market Size by DPP-4 Inhibitors (US$ Million), 2020-2029
Figure 27: Diabetes Devices and Therapeutics Market Size by SGLT-2 Inhibitors (US$ Million), 2020-2029
Figure 28: Diabetes Devices and Therapeutics Market Share by Insulin (%), 2020-2029
Figure 29: Diabetes Devices and Therapeutics Market Size by Basal or Long-Acting, by Value (US$ Million), 2020-2029
Figure 30: Diabetes Devices and Therapeutics Market Size by Bolus or Fast-Acting, by Value (US$ Million), 2020-2029
Figure 31: Diabetes Devices and Therapeutics Market Size by Traditional Human Insulin Drugs, by Value (US$ Million), 2020-2029
Figure 32: Diabetes Devices and Therapeutics Market Size by Insulin Biosimilars, by Value (US$ Million), 2020-2029
Figure 33: Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs (%), 2020-2029
Figure 34: Diabetes Devices and Therapeutics Market Size by GLP-1 Receptor Agonists, by Value (US$ Million), 2020-2029
Figure 35: Diabetes Devices and Therapeutics Market Size by Amylin Analogue, by Value (US$ Million), 2020-2029
Figure 36: Diabetes Devices and Therapeutics Market Share by Combination Drugs (%), 2020-2029
Figure 37: Diabetes Devices and Therapeutics Market Size by Combination Insulin, by Value (US$ Million), 2020-2029
Figure 38: Diabetes Devices and Therapeutics Market Size by Oral Combination, by Value (US$ Million), 2020-2029
Figure 39: Diabetes Devices and Therapeutics Market Share by Route of Administration (%), 2020-2029
Figure 40: Diabetes Devices and Therapeutics Market Size by Subcutaneous, by Value (US$ Million), 2020-2029
Figure 41: Diabetes Devices and Therapeutics Market Size by Intravenous, by Value (US$ Million), 2020-2029
Figure 42: Diabetes Devices and Therapeutics Market Size by Others, by Value (US$ Million), 2020-2029
Figure 43: Diabetes Devices and Therapeutics Market Share by Type of Diabetes (%), 2020-2029
Figure 44: Diabetes Devices and Therapeutics Market Size by Type 2 Diabetes, by Value (US$ Million), 2020-2029
Figure 45: Diabetes Devices and Therapeutics Market Size by Type 1 Diabetes, by Value (US$ Million), 2020-2029
Figure 46: Diabetes Devices and Therapeutics Market Share by Distribution Channels (%), 2020-2029
Figure 47: Diabetes Devices and Therapeutics Market Size by Online Pharmacies, by Value (US$ Million), 2020-2029
Figure 48: Diabetes Devices and Therapeutics Market Size by Hospital Pharmacies, by Value (US$ Million), 2020-2029
Figure 49: Diabetes Devices and Therapeutics Market Size by Retail Pharmacies, by Value (US$ Million), 2020-2029
Figure 50: Diabetes Devices and Therapeutics Market Share by End User (%), 2020-2029
Figure 51: Diabetes Devices and Therapeutics Market Size by Hospitals, by Value (US$ Million), 2020-2029
Figure 52: Diabetes Devices and Therapeutics Market Size by Diabetes Clinics, by Value (US$ Million), 2020-2029
Figure 53: Diabetes Devices and Therapeutics Market Size by Homecare, by Value (US$ Million), 2020-2029
